F

Amicus Therapeutics
D

FOLD

7.99500
USD
0.02
(0.19%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
-
P/E
-44
حجم السوق
2,456,382,521
أصول ذات صلة
C
CRSP
-1.550
(-4.53%)
32.650 USD
E
EDIT
-0.07000
(-5.88%)
1.12000 USD
G
GLPG
-0.390
(-1.59%)
24.100 USD
N
NTLA
-0.42000
(-5.75%)
6.88500 USD
P
PTCT
-1.650
(-3.41%)
46.750 USD
S
SGMO
0.13500
(21.77%)
0.75510 USD
S
SRPT
-3.820
(-6.11%)
58.670 USD
المزيد
الأخبار المقالات

العنوان: Amicus Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants;a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.